TD Cowen Downgrades Bio-Techne to Hold, Raises Price Target to $73
TD Cowen analyst Kyle Boucher downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold and raises the price target from $65 to $73.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.